首页> 外文OA文献 >Prediction System for Prostate Cancer Recurrence Using Machine Learning
【2h】

Prediction System for Prostate Cancer Recurrence Using Machine Learning

机译:采用机器学习前列腺癌复发预测系统

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Prostate cancer is the fourth most common cancer affecting South Korean males, and the biochemical recurrence (BCR) of prostate cancer occurs in approximately 25% of patients five years after radical prostatectomy. The ability to predict BCR would help clinicians and patients to make better treatment decisions. Therefore, in this study, we have proposed a web-based clinical decision support system that predicts the BCR of prostate cancer in Korean patients. The data were obtained from the Korean Prostate Cancer Registry (KPCR) database, which contained information about 7394 patients with prostate cancer who were treated at one of the six major medical institutions in South Korea between May 2001 and December 2014. We tested 13 prediction models and selected the gradient boosting classifier because it demonstrated excellent prediction performance. Using this model, we were able to create a web application and once clinical data from patients were entered, the three- and five-year post-surgery BCR predictions could be extracted. We developed a clinical decision support system to provide a prostate cancer BCR predictive function to facilitate postoperative follow-up and clinical management. This system will help clinicians develop a strategic approach for prostate cancer treatment by predicting the likelihood of prostate cancer recurrence.
机译:前列腺癌是影响韩国男性的第四个最常见的癌症,并且前列腺癌的生化复发(BCR)在自由基前列腺切除术后五年的患者的约25%发生。预测BCR的能力将有助于临床医生和患者做出更好的治疗决策。因此,在本研究中,我们提出了一种基于网络的临床决策支持系统,其预测韩国患者前列腺癌的BCR。从朝鲜前列腺癌症登记处(KPCR)数据库,该数据库包含约7394例前列腺癌患者谁是在韩国2001年5月和2014年12月间的六大医疗机构中的一种处理信息获得的数据,我们测试13个的预测模型并选择渐变升压分类器,因为它展示了出色的预测性能。使用此模型,我们能够创建网络应用程序,一旦进入患者的临床数据,就可以提取三年和五年后的手术后BCR预测。我们开发了一种临床决策支持系统,提供前列腺癌BCR预测功能,以促进术后随访和临床管理。该系统将通过预测前列腺癌复发的可能性,帮助临床医生制定前列腺癌治疗的战略方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号